These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10148446)

  • 1. Repeated measurements over time: statistical analysis of the angiographic outcomes in the Probucol Quantitative Regression Swedish Trial (PQRST).
    Holme I; Malmaeus I; Olsson AG; Nilsson S; Walldius G
    Clin Trials Metaanal; 1993 Mar; 28(2):95-108. PubMed ID: 10148446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.
    Johansson J; Olsson AG; Bergstrand L; Elinder LS; Nilsson S; Erikson U; Mölgaard J; Holme I; Walldius G
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1049-56. PubMed ID: 7627695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
    Walldius G; Erikson U; Olsson AG; Bergstrand L; Hådell K; Johansson J; Kaijser L; Lassvik C; Mölgaard J; Nilsson S
    Am J Cardiol; 1994 Nov; 74(9):875-83. PubMed ID: 7977117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipids and antioxidative factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST).
    Walldius G; Regnström J; Nilsson J; Johansson J; Schäfer-Elinder L; Moelgaard J; Hådell K; Olsson AG; Carlson LA
    Am J Cardiol; 1993 Feb; 71(6):15B-19B. PubMed ID: 8434556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol Quantitative Regression Swedish Trial: new angiographic technique to measure atheroma volume of the femoral artery.
    Erikson U; Nilsson S; Stenport G
    Am J Cardiol; 1988 Jul; 62(3):44B-47B. PubMed ID: 3293416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.
    Hodis HN; Mack WJ; LaBree L; Cashin-Hemphill L; Sevanian A; Johnson R; Azen SP
    JAMA; 1995 Jun; 273(23):1849-54. PubMed ID: 7776501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of heterozygous familial hypercholesterolemia showing the regression of coronary atherosclerosis by LDL-apheresis].
    Nomura S; Kouzuma R; Komura T; Sadayasu T; Segawa J; Nakashima Y; Kuroiwa A
    Kokyu To Junkan; 1992 Mar; 40(3):299-302. PubMed ID: 1579754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probucol on elderly hypercholesterolemic patients in the FAST study.
    Sawayama Y; Maeda S; Ohnishi H; Okada K; Hayashi J
    Fukuoka Igaku Zasshi; 2006 Jan; 97(1):15-24. PubMed ID: 16613215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of coronary atherosclerosis. Angiographic perspective.
    Waters DD; Lespérance J
    Drugs; 1988; 36 Suppl 3():37-42. PubMed ID: 3076119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the selection of angiographic projections on the results of coronary angiographic follow-up trials. International Nifedipine Trial on Antiatherosclerotic Therapy Investigators.
    Jost S; Deckers J; Nikutta P; Reiber JH; Rafflenbeul W; Wiese B; Hecker H; Lichtlen P
    Am Heart J; 1995 Sep; 130(3 Pt 1):433-9. PubMed ID: 7661057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative coronary angiography: progression and regression of coronary stenoses--an intervention study with fenofibrate].
    Hahmann HW; Bunte T; Hellwig N; Hau U; Becker D; Dyckmans J; Keller HE; Schieffer HJ
    Z Kardiol; 1991 Oct; 80(10):589-94. PubMed ID: 1771957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression and stabilization of coronary artery lesions. Angiographic trials move beyond the NCEP treatment guidelines.
    DeBoer LW; Vailas LI
    Nebr Med J; 1992 Jun; 77(6):124-9. PubMed ID: 1620266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages and limitations of serial coronary arteriography for the assessment of progression and regression of coronary atherosclerosis. Implications for clinical trials.
    Waters D; Lespérance J; Craven TE; Hudon G; Gillam LD
    Circulation; 1993 Mar; 87(3 Suppl):II38-47. PubMed ID: 8443922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Computer-assisted geometric measuring technic in coronary angiography interval studies: results of initial angiograms of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT) study].
    Jost S; Deckers J; Nellessen U; Rafflenbeul W; Hecker H; Reiber JH; Lippolt P; Hugenholtz PG; Lichtlen PR
    Z Kardiol; 1989 Jan; 78(1):23-32. PubMed ID: 2646838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral artery.
    Bergstrand L; Erikson U; Holme I; Johansson J; Olsson AG; Mølgaard J; Nilsson S; Stenport G; Walldius G
    Acta Radiol; 1993 Nov; 34(6):612-7. PubMed ID: 8240898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression.
    Marchioli R; Prieto JC; Tognoni G
    Clin Trials Metaanal; 1994 Oct; 29(2-3):139-76. PubMed ID: 10150224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoral and coronary atherosclerosis in patients with hyperlipidaemia. Arteriographic findings correlated to clinical and biochemical parameters.
    Bergstrand L
    Acta Radiol Suppl; 1994; 392():1-27. PubMed ID: 8184697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.